3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Leukemia, Myeloid, Acute
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Primary Myelofibrosis
12
Polycythemia Vera
11
Myelodysplastic Syndromes
10
Leukemia
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Myeloproliferative Disorders
8
Recurrence
6
Leukemia, Myelomonocytic, Chronic
6
Hematologic Neoplasms
6
Breast Neoplasms
6
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, T-Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Graft vs Host Disease
5
Thrombocythemia, Essential
4
Leukemia, Myeloid, Chronic-Phase
4
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Prolymphocytic, T-Cell
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Interventions
Tamoxifen
16
Radiotherapy
9
Anastrozole
8
Letrozole
7
Chemotherapy, Adjuvant
7
Specimen Handling
6
Radiation
5
Neoadjuvant Therapy
5
Mastectomy, Segmental
5
Biopsy
5
Sentinel Lymph Node Biopsy
4
Psychiatric Rehabilitation
4
Mass Spectrometry
4
Immunohistochemistry
4
Gene Expression Profiling
4
Early Intervention, Educational
4
Counseling
4
exemestane
3
afimoxifene
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Methods
3
Mastectomy
3
Magnetic Resonance Spectroscopy
3
Fatty Acids, Omega-3
3
Chromatography, High Pressure Liquid
3
pasireotide
2
Trastuzumab
2
Standard of Care
2
Soybean Proteins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Intraductal, Noninfiltrating
×
ruxolitinib
×
Clear all
NCT02928978
2026-04-13
TBCRC042
Baylor Breast Care Center
Phase 2
Completed
84 enrolled